The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best small-cap value stocks to buy. On April 24, H.C. Wainwright reiterated a Buy rating on Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) and a $55 price target.

The bullish stance is in response to positive discussions with the company’s senior management, including President and CEO Jeff Dayno, newly appointed CFO Glenn Reicin, and Head of Investor Relations Brennan Doyle. The discussions centered on patent infringement claims against AET Pharma and Sandoz.

The patent in question covers new pitolisant formulations that expand IP protection for WAKIX beyond its pure crystalline polymorph formulation. Harmony Biosciences has already granted Novitum Pharma an exclusive license to manufacture its generic version of pitolisant, including an amorphous formulation.

Analysts at Oppenheimer have already raised Harmony Biosciences’ price target to $72 while maintaining an outperform rating, buoyed by the company’s strong patent portfolio. The company is also accelerating the development of Clemizole Hydrochloride (EPX-100) for the treatment of Dravet Syndrome and Lennox-Gastaut Syndrome.

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients with rare neurological diseases. Their primary product is WAKIX (pitolisant), a first-in-class medicine approved by the FDA for the treatment of excessive daytime sleepiness or cataplexy in adult patients with narcolepsy.

While we acknowledge the potential of HRMY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Most Oversold Canadian Stocks to Invest In and 10 Best Stocks to Buy in 2026 According to Billionaire George Soros.

Disclosure: None. Follow Insider Monkey on Google News.